![Wen Kai Xiang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wen Kai Xiang
Directeur/Membre du Conseil chez
Immunitas Therapeutics, Inc.
Profil
Wen Kai Xiang is currently a Director at Immunitas Therapeutics, Inc. He previously worked as a Managing Director at Burrill LLC, a Portfolio Manager at Franklin Advisers, Inc., an Associate at The Biotechnology Greenhouse Corp.
of Southeastern PA, and a Vice President-Business Development at Genyous Biomed International, Inc. He also served as a Director at Acacia Research Corp., Gossamer Bio, Inc., Viela Bio, Inc., and Transcenta Holding Ltd. Prior to his career in business, he worked as a Research Associate at Sinopharm Group Co., Ltd. Dr. Xiang holds an MBA from the University of Pennsylvania, a doctorate from Stony Brook University, and an undergraduate degree from Fudan University.
Postes actifs de Wen Kai Xiang
| Sociétés | Poste | Début |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Wen Kai Xiang
| Sociétés | Poste | Fin |
|---|---|---|
Franklin Advisers, Inc.
 Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers provides advisory services to a range of products and separate accounts which utilize various investment strategies including equity, fixed income, core, hybrid, and multi-asset strategies. The firm employs fundamental, bottom-up investment analysis to select securities within a specific sector or industry. | Analyst-Equity | 31/10/2011 |
Genyous Biomed International, Inc.
 Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Develops platform to create multivalent molecularly directed therapies | Corporate Officer/Principal | 31/12/2003 |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Corporate Officer/Principal | - |
| ACACIA RESEARCH CORPORATION | Corporate Officer/Principal | - |
| SINOPHARM GROUP CO. LTD. | Corporate Officer/Principal | 01/07/1992 |
Formation de Wen Kai Xiang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Sinopharm Group Co., Ltd.
 Sinopharm Group Co., Ltd. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical devices & operates retail pharmacies | Distribution Services |
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers provides advisory services to a range of products and separate accounts which utilize various investment strategies including equity, fixed income, core, hybrid, and multi-asset strategies. The firm employs fundamental, bottom-up investment analysis to select securities within a specific sector or industry. | Finance |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genyous Biomed International, Inc.
Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Develops platform to create multivalent molecularly directed therapies | Technology Services |
Acacia Research Corp.
 Acacia Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in patent licensing, printers manufacturing and oil & natural gas exploration & production business | Commercial Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Transcenta Holding Ltd.
 Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
